Unicycive Therapeutics (UNCY) Other Operating Expenses (2020 - 2023)

Unicycive Therapeutics (UNCY) has 4 years of Other Operating Expenses data on file, last reported at $1.6 million in Q3 2023.

• For the quarter ending Q3 2023, Other Operating Expenses rose 53600.0% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2024 stood at $1.6 million (up 108.83% YoY), and the FY2021 full-year result was $8.0 million, up 852.56% from the prior year.
• Other Operating Expenses for Q3 2023 stood at $1.6 million, up from $484000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $6.6 million in Q4 2021 and bottomed at -$10.4 million in Q1 2023.
• The 4-year median for Other Operating Expenses is $484000.0 (2023), against an average of -$415636.4.
• The widest annual swing landed in 2022, when Other Operating Expenses slumped 225.33%; it then jumped 53600.0% in 2023.
• A 4-year view of Other Operating Expenses shows it stood at $841000.0 in 2020, then soared by 686.8% to $6.6 million in 2021, then plunged by 225.33% to -$8.3 million in 2022, then surged by 119.35% to $1.6 million in 2023.
• The last three Other Operating Expenses figures came in at $1.6 million (Q3 2023), $484000.0 (Q2 2023), and -$10.4 million (Q1 2023), per Business Quant data.

Peer Comparison